A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
The “2022 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2022 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and other technologies that may disrupt the market.
The Centers for Disease Control and Prevention (CDC) is urging immediate discontinuation of the use of EzriCare Artificial Tears, an over-the-counter drop for dry eye, after linking various infecti...
Johnson & Johnson reported Jan. 24 that its full year 2022 global surgical vision revenue was $1.31 billion, a 4.6 percent increase (+9.4 percent cc) over $1.25 billion in 2021. Revenue was up 2.0 ...
Japan-based Nidek has issued a field safety notice for all lots of EyeCee One preloaded and EyeCee One Crystal preloaded intraocular lenses (IOLs). The lenses are distributed by Bausch + Lomb. Nide...
The Federal Trade Commission announced Jan. 19 that it had issued an order requiring Ohio-based LCA-Vision, doing business as LasikPlus and Joffe MediCenter, to pay $1.25 million for using deceptiv...
Iantrek, of White Plains, New York, announced Jan. 23 that its novel biostenting procedure reduced intraocular pressure (IOP) nearly 40 percent in a first-in-human trial of 10 patients with open-an...
Sun Pharmaceutical Industries Limited of India received a warning letter from the US FDA dated Dec. 15, 2022, regarding “significant violations” of Current Good Manufacturing Practice (CGMP) regula...
EyePoint Pharmaceuticals announced Jan. 23 that it plans to build a 40 thousand-square-foot manufacturing facility in Northbridge, Massachusetts, to support the global manufacturing of Yutiq and it...
Oxular Limited, of Oxford, UK, announced Jan. 24 that the US FDA had cleared its investigational new drug application for a Phase II trial of suprachoroidal OXU-001 in diabetic macular edema (DME)....
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayA Multi-Step Approach for Accurate & Timely Data
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.